Atara Biotherapeutics Inc. buy melinda
Start price
13.01.18
/
50%
€25.35
Target price
22.01.18
€28.41
Performance (%)
15.84%
End price
22.01.18
€29.36
Summary
This prediction ended on 22.01.18 with a price of €29.36. The prediction had a final performance of 15.84%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Atara Biotherapeutics Inc. | - | - | - | - |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% | 68.786% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% | 100.066% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% | 43.024% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% | 63.222% |
According to melinda what are the pros and cons of Atara Biotherapeutics Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Atara Biotherapeutics Inc. diskutieren
Biotechnologie und medizinische SecteurRecherche
10. Januar 2018 1H 2019 durch Daten - die Genehmigung erhalten , die Notierung an US - Standorten zu initiieren.
Stopped prediction by melinda for Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€5.79
17.03.20
17.03.20
€15.00
04.11.21
04.11.21
200.79%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Atara Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€7.27
12.03.20
12.03.20
€12.00
17.03.20
17.03.20
-20.36%
17.03.20
17.03.20
Could be worthwhile Investment >10% per year
Atara Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€36.68
03.04.19
03.04.19
€40.59
30.10.19
30.10.19
-73.34%
30.10.19
30.10.19
Could be worthwhile Investment >10% per year